SAR Analysis of Novel Coxsackie virus A9 Capsid Binders
Enterovirus infections are common in humans, yet there are no approved antiviral treatments. In this study we concentrated on inhibition of one of the Enterovirus B (EV-B), namely Coxsackievirus A9 (CVA9), using a combination of medicinal chemistry, virus inhibition assays, structure determination f...
Gespeichert in:
| Veröffentlicht in: | Journal of medicinal chemistry 2024-10, Vol.67 (19), p.17144-17161 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 17161 |
|---|---|
| container_issue | 19 |
| container_start_page | 17144 |
| container_title | Journal of medicinal chemistry |
| container_volume | 67 |
| creator | Tammaro, Chiara Plavec, Zlatka Myllymäki, Laura Mitchell, Cristopher Consalvi, Sara Biava, Mariangela Ciogli, Alessia Domanska, Aušra Leppilampi, Valtteri Buckner, Cienna Manetto, Simone Sciò, Pietro Coluccia, Antonio Laajala, Mira Dondio, Giulio M. Bigogno, Chiara Marjomäki, Varpu Butcher, Sarah J. Poce, Giovanna |
| description | Enterovirus infections are common in humans, yet there are no approved antiviral treatments. In this study we concentrated on inhibition of one of the Enterovirus B (EV-B), namely Coxsackievirus A9 (CVA9), using a combination of medicinal chemistry, virus inhibition assays, structure determination from cryogenic electron microscopy and molecular modeling, to determine the structure activity relationships for a promising class of novel N-phenylbenzylamines. Of the new 29 compounds synthesized, 10 had half maximal effective concentration (EC50) values between 0.64–10.46 μM, and of these, 7 had 50% cytotoxicity concentration (CC50) values higher than 200 μM. In addition, this new series of compounds showed promising physicochemical properties and act through capsid stabilization, preventing capsid expansion and subsequent release of the genome. |
| doi_str_mv | 10.1021/acs.jmedchem.4c00701 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3106732010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3106732010</sourcerecordid><originalsourceid>FETCH-LOGICAL-a227t-a49be855640877b547b03e2d0a64562d109beec37aac15acccaf5b2e99505b1e3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwBwh5ySZl_IqbZYl4SRVIPNaW4zgiJWmKp6no32Noy5LVSDPn3pEOIecMxgw4u7IOx_PWl-7dt2PpADSwAzJkikMiJyAPyRCA84SnXAzICeIcAATj4pgMRMazuIch0S_TZzpd2GaDNdKuoo_d2jc0777Quo_a03UdeqTTjOZ2iXVJr-tF6QOekqPKNujPdnNE3m5vXvP7ZPZ095BPZ4nlXK8SK7PCT5RKJUy0LpTUBQjPS7CpVCkvGcS7d0Jb65iyzjlbqYL7LFOgCubFiFxue5eh--w9rkxbo_NNYxe-69EIBqkWHBhEVG5RFzrE4CuzDHVrw8YwMD_KTFRm9srMTlmMXew-9EW8_YX2jiIAW-A33vUh2sL_O78BYeV5Cw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3106732010</pqid></control><display><type>article</type><title>SAR Analysis of Novel Coxsackie virus A9 Capsid Binders</title><source>American Chemical Society Journals</source><creator>Tammaro, Chiara ; Plavec, Zlatka ; Myllymäki, Laura ; Mitchell, Cristopher ; Consalvi, Sara ; Biava, Mariangela ; Ciogli, Alessia ; Domanska, Aušra ; Leppilampi, Valtteri ; Buckner, Cienna ; Manetto, Simone ; Sciò, Pietro ; Coluccia, Antonio ; Laajala, Mira ; Dondio, Giulio M. ; Bigogno, Chiara ; Marjomäki, Varpu ; Butcher, Sarah J. ; Poce, Giovanna</creator><creatorcontrib>Tammaro, Chiara ; Plavec, Zlatka ; Myllymäki, Laura ; Mitchell, Cristopher ; Consalvi, Sara ; Biava, Mariangela ; Ciogli, Alessia ; Domanska, Aušra ; Leppilampi, Valtteri ; Buckner, Cienna ; Manetto, Simone ; Sciò, Pietro ; Coluccia, Antonio ; Laajala, Mira ; Dondio, Giulio M. ; Bigogno, Chiara ; Marjomäki, Varpu ; Butcher, Sarah J. ; Poce, Giovanna</creatorcontrib><description>Enterovirus infections are common in humans, yet there are no approved antiviral treatments. In this study we concentrated on inhibition of one of the Enterovirus B (EV-B), namely Coxsackievirus A9 (CVA9), using a combination of medicinal chemistry, virus inhibition assays, structure determination from cryogenic electron microscopy and molecular modeling, to determine the structure activity relationships for a promising class of novel N-phenylbenzylamines. Of the new 29 compounds synthesized, 10 had half maximal effective concentration (EC50) values between 0.64–10.46 μM, and of these, 7 had 50% cytotoxicity concentration (CC50) values higher than 200 μM. In addition, this new series of compounds showed promising physicochemical properties and act through capsid stabilization, preventing capsid expansion and subsequent release of the genome.</description><identifier>ISSN: 0022-2623</identifier><identifier>ISSN: 1520-4804</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.4c00701</identifier><identifier>PMID: 39292620</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2024-10, Vol.67 (19), p.17144-17161</ispartof><rights>2024 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a227t-a49be855640877b547b03e2d0a64562d109beec37aac15acccaf5b2e99505b1e3</cites><orcidid>0000-0002-7538-2424 ; 0009-0009-7679-0700 ; 0000-0002-7940-8206 ; 0000-0001-5023-3804 ; 0000-0002-4592-5926 ; 0000-0001-7466-8861</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00701$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.4c00701$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39292620$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tammaro, Chiara</creatorcontrib><creatorcontrib>Plavec, Zlatka</creatorcontrib><creatorcontrib>Myllymäki, Laura</creatorcontrib><creatorcontrib>Mitchell, Cristopher</creatorcontrib><creatorcontrib>Consalvi, Sara</creatorcontrib><creatorcontrib>Biava, Mariangela</creatorcontrib><creatorcontrib>Ciogli, Alessia</creatorcontrib><creatorcontrib>Domanska, Aušra</creatorcontrib><creatorcontrib>Leppilampi, Valtteri</creatorcontrib><creatorcontrib>Buckner, Cienna</creatorcontrib><creatorcontrib>Manetto, Simone</creatorcontrib><creatorcontrib>Sciò, Pietro</creatorcontrib><creatorcontrib>Coluccia, Antonio</creatorcontrib><creatorcontrib>Laajala, Mira</creatorcontrib><creatorcontrib>Dondio, Giulio M.</creatorcontrib><creatorcontrib>Bigogno, Chiara</creatorcontrib><creatorcontrib>Marjomäki, Varpu</creatorcontrib><creatorcontrib>Butcher, Sarah J.</creatorcontrib><creatorcontrib>Poce, Giovanna</creatorcontrib><title>SAR Analysis of Novel Coxsackie virus A9 Capsid Binders</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Enterovirus infections are common in humans, yet there are no approved antiviral treatments. In this study we concentrated on inhibition of one of the Enterovirus B (EV-B), namely Coxsackievirus A9 (CVA9), using a combination of medicinal chemistry, virus inhibition assays, structure determination from cryogenic electron microscopy and molecular modeling, to determine the structure activity relationships for a promising class of novel N-phenylbenzylamines. Of the new 29 compounds synthesized, 10 had half maximal effective concentration (EC50) values between 0.64–10.46 μM, and of these, 7 had 50% cytotoxicity concentration (CC50) values higher than 200 μM. In addition, this new series of compounds showed promising physicochemical properties and act through capsid stabilization, preventing capsid expansion and subsequent release of the genome.</description><issn>0022-2623</issn><issn>1520-4804</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EoqXwBwh5ySZl_IqbZYl4SRVIPNaW4zgiJWmKp6no32Noy5LVSDPn3pEOIecMxgw4u7IOx_PWl-7dt2PpADSwAzJkikMiJyAPyRCA84SnXAzICeIcAATj4pgMRMazuIch0S_TZzpd2GaDNdKuoo_d2jc0777Quo_a03UdeqTTjOZ2iXVJr-tF6QOekqPKNujPdnNE3m5vXvP7ZPZ095BPZ4nlXK8SK7PCT5RKJUy0LpTUBQjPS7CpVCkvGcS7d0Jb65iyzjlbqYL7LFOgCubFiFxue5eh--w9rkxbo_NNYxe-69EIBqkWHBhEVG5RFzrE4CuzDHVrw8YwMD_KTFRm9srMTlmMXew-9EW8_YX2jiIAW-A33vUh2sL_O78BYeV5Cw</recordid><startdate>20241010</startdate><enddate>20241010</enddate><creator>Tammaro, Chiara</creator><creator>Plavec, Zlatka</creator><creator>Myllymäki, Laura</creator><creator>Mitchell, Cristopher</creator><creator>Consalvi, Sara</creator><creator>Biava, Mariangela</creator><creator>Ciogli, Alessia</creator><creator>Domanska, Aušra</creator><creator>Leppilampi, Valtteri</creator><creator>Buckner, Cienna</creator><creator>Manetto, Simone</creator><creator>Sciò, Pietro</creator><creator>Coluccia, Antonio</creator><creator>Laajala, Mira</creator><creator>Dondio, Giulio M.</creator><creator>Bigogno, Chiara</creator><creator>Marjomäki, Varpu</creator><creator>Butcher, Sarah J.</creator><creator>Poce, Giovanna</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7538-2424</orcidid><orcidid>https://orcid.org/0009-0009-7679-0700</orcidid><orcidid>https://orcid.org/0000-0002-7940-8206</orcidid><orcidid>https://orcid.org/0000-0001-5023-3804</orcidid><orcidid>https://orcid.org/0000-0002-4592-5926</orcidid><orcidid>https://orcid.org/0000-0001-7466-8861</orcidid></search><sort><creationdate>20241010</creationdate><title>SAR Analysis of Novel Coxsackie virus A9 Capsid Binders</title><author>Tammaro, Chiara ; Plavec, Zlatka ; Myllymäki, Laura ; Mitchell, Cristopher ; Consalvi, Sara ; Biava, Mariangela ; Ciogli, Alessia ; Domanska, Aušra ; Leppilampi, Valtteri ; Buckner, Cienna ; Manetto, Simone ; Sciò, Pietro ; Coluccia, Antonio ; Laajala, Mira ; Dondio, Giulio M. ; Bigogno, Chiara ; Marjomäki, Varpu ; Butcher, Sarah J. ; Poce, Giovanna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a227t-a49be855640877b547b03e2d0a64562d109beec37aac15acccaf5b2e99505b1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tammaro, Chiara</creatorcontrib><creatorcontrib>Plavec, Zlatka</creatorcontrib><creatorcontrib>Myllymäki, Laura</creatorcontrib><creatorcontrib>Mitchell, Cristopher</creatorcontrib><creatorcontrib>Consalvi, Sara</creatorcontrib><creatorcontrib>Biava, Mariangela</creatorcontrib><creatorcontrib>Ciogli, Alessia</creatorcontrib><creatorcontrib>Domanska, Aušra</creatorcontrib><creatorcontrib>Leppilampi, Valtteri</creatorcontrib><creatorcontrib>Buckner, Cienna</creatorcontrib><creatorcontrib>Manetto, Simone</creatorcontrib><creatorcontrib>Sciò, Pietro</creatorcontrib><creatorcontrib>Coluccia, Antonio</creatorcontrib><creatorcontrib>Laajala, Mira</creatorcontrib><creatorcontrib>Dondio, Giulio M.</creatorcontrib><creatorcontrib>Bigogno, Chiara</creatorcontrib><creatorcontrib>Marjomäki, Varpu</creatorcontrib><creatorcontrib>Butcher, Sarah J.</creatorcontrib><creatorcontrib>Poce, Giovanna</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tammaro, Chiara</au><au>Plavec, Zlatka</au><au>Myllymäki, Laura</au><au>Mitchell, Cristopher</au><au>Consalvi, Sara</au><au>Biava, Mariangela</au><au>Ciogli, Alessia</au><au>Domanska, Aušra</au><au>Leppilampi, Valtteri</au><au>Buckner, Cienna</au><au>Manetto, Simone</au><au>Sciò, Pietro</au><au>Coluccia, Antonio</au><au>Laajala, Mira</au><au>Dondio, Giulio M.</au><au>Bigogno, Chiara</au><au>Marjomäki, Varpu</au><au>Butcher, Sarah J.</au><au>Poce, Giovanna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SAR Analysis of Novel Coxsackie virus A9 Capsid Binders</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2024-10-10</date><risdate>2024</risdate><volume>67</volume><issue>19</issue><spage>17144</spage><epage>17161</epage><pages>17144-17161</pages><issn>0022-2623</issn><issn>1520-4804</issn><eissn>1520-4804</eissn><abstract>Enterovirus infections are common in humans, yet there are no approved antiviral treatments. In this study we concentrated on inhibition of one of the Enterovirus B (EV-B), namely Coxsackievirus A9 (CVA9), using a combination of medicinal chemistry, virus inhibition assays, structure determination from cryogenic electron microscopy and molecular modeling, to determine the structure activity relationships for a promising class of novel N-phenylbenzylamines. Of the new 29 compounds synthesized, 10 had half maximal effective concentration (EC50) values between 0.64–10.46 μM, and of these, 7 had 50% cytotoxicity concentration (CC50) values higher than 200 μM. In addition, this new series of compounds showed promising physicochemical properties and act through capsid stabilization, preventing capsid expansion and subsequent release of the genome.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>39292620</pmid><doi>10.1021/acs.jmedchem.4c00701</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-7538-2424</orcidid><orcidid>https://orcid.org/0009-0009-7679-0700</orcidid><orcidid>https://orcid.org/0000-0002-7940-8206</orcidid><orcidid>https://orcid.org/0000-0001-5023-3804</orcidid><orcidid>https://orcid.org/0000-0002-4592-5926</orcidid><orcidid>https://orcid.org/0000-0001-7466-8861</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-2623 |
| ispartof | Journal of medicinal chemistry, 2024-10, Vol.67 (19), p.17144-17161 |
| issn | 0022-2623 1520-4804 1520-4804 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3106732010 |
| source | American Chemical Society Journals |
| title | SAR Analysis of Novel Coxsackie virus A9 Capsid Binders |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T15%3A58%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SAR%20Analysis%20of%20Novel%20Coxsackie%20virus%20A9%20Capsid%20Binders&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Tammaro,%20Chiara&rft.date=2024-10-10&rft.volume=67&rft.issue=19&rft.spage=17144&rft.epage=17161&rft.pages=17144-17161&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.4c00701&rft_dat=%3Cproquest_cross%3E3106732010%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3106732010&rft_id=info:pmid/39292620&rfr_iscdi=true |